European Nuclear Medicine/Radiopharmaceuticals Market worth $1.62 Billion by 2020 - PowerPoint PPT Presentation

Loading...

PPT – European Nuclear Medicine/Radiopharmaceuticals Market worth $1.62 Billion by 2020 PowerPoint presentation | free to download - id: 82169e-OGZhN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

European Nuclear Medicine/Radiopharmaceuticals Market worth $1.62 Billion by 2020

Description:

This report studies the European nuclear medicine/radiopharmaceuticals market for the forecast period of 2015 to 2020. This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020). – PowerPoint PPT presentation

Number of Views:25
Slides: 12
Provided by: Priya130

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: European Nuclear Medicine/Radiopharmaceuticals Market worth $1.62 Billion by 2020


1
MarketsandMarkets Presents
European Nuclear Medicine/Radiopharmaceuticals
Market worth 1.62 Billion by 2020

http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
2
The report European Nuclear Medicine/Radiopharmac
euticals Market by Type (Diagnostic (SPECT -
Technetium, PET - F-18), Therapeutic (Beta
Emitters - I-131, Alpha Emitters, Brachytherapy -
Y-90)), by Application (Oncology, Thyroid,
Cardiology) - Forecasts to 2020, analyzes and
studies the major market drivers, restraints,
challenges, and opportunities. Browse 145 market
data tables and 60 figures spread through 195
pages and in-depth TOC on European Nuclear
Medicine/Radiopharmaceuticals Market by Type
(Diagnostic (SPECT - Technetium, PET - F-18),
Therapeutic (Beta Emitters - I-131, Alpha
Emitters, Brachytherapy - Y-90)), by Application
(Oncology, Thyroid, Cardiology) - Forecasts to
2020 http//www.marketsandmarkets.com/Market-Rep
orts/european-nuclear-medicine-radiopharmaceutical
s-market-1107.html
 
http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
3
Early buyers will receive 10 customization on
this report.

 
http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
4
  • This report studies the European nuclear
    medicine/radiopharmaceuticals market for the
    forecast period of 2015 to 2020. This market is
    expected to reach 1.62 Billion by 2020 from
    1.09 Billion in 2015, at a CAGR of 8.2 during
    the forecast period (2015 to 2020).
  • The European nuclear medicine/radiopharmaceuticals
    market is segmented on the basis of type,
    application, and country.


http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
5
  • Based on type, the European nuclear
    medicine/radiopharmaceuticals market is
    categorized into diagnostic and therapeutic
    radioisotopes. In 2015, the diagnostic segment
    accounts for a major share of the European
    nuclear medicine/radiopharmaceuticals market. The
    diagnostic radiopharmaceuticals market is further
    segmented into SPECT and PET radioisotopes. In
    2015, the SPECT segment accounts for the largest
    share of the European nuclear medicine/radiopharma
    ceuticals diagnostic market. The therapeutic
    radiopharmaceuticals market is further segmented
    into beta emitters, alpha emitters, and
    brachytherapy. In 2015, the beta emitters segment
    accounts for the largest share of the European
    nuclear medicine/radiopharmaceuticals therapeutic
    market.


http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
6
  • Based on application, the European nuclear
    medicine/radiopharmaceuticals market is segmented
    into SPECT, PET, and therapeutic applications. In
    2015, the cardiology application accounts for the
    largest share of European nuclear medicine SPECT
    market. The PET market is dominated by oncology
    applications and therapeutic market is dominated
    by thyroid applications.


http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
7
  • On the basis of country, the market is divided
    into Germany, France, Italy, U.K., Spain, Russia,
    and the Rest of Europe (RoE). The Rest of Europe
    comprises Sweden, Switzerland, Poland, Denmark,
    The Netherlands, and Belgium, among others. In
    2015, Germany accounts for the largest share of
    the European nuclear medicine/radiopharmaceuticals
    market, followed by France, Italy, and U.K.

http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
8
  • Factors such as increasing preference for SPECT
    and PET scans, advances in radiotracers, advent
    of alpha radio immunotherapy-based targeted
    cancer treatment, increasing incidence
    mortality rate of cancer and cardiac ailments are
    driving the growth of this market. However,
    factors such as shorter half-life of
    radiopharmaceuticals, competition from
    conventional diagnostic procedures are hindering
    the growth of this market.

http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
9
  • Some of the major players in the European nuclear
    medicine market include Cardinal Health Inc.
    (U.S.), GE Healthcare (U.K.), Bracco Imaging
    S.p.A (Italy), Eczacibasi-Monrol Nuclear Products
    (Turkey), Nordion, Inc. (Canada), Advanced
    Accelerator Applications S.A. (France), Bayer
    Healthcare (Germany), Lantheus Medical Imaging,
    Inc. (U.S.), IBA Molecular Imaging (Belgium), and
    Mallinckrodt plc (Ireland).

http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
10
Contact Us
Contact Mr. Rohan Markets and Markets UNIT no
802, Tower no. 7, SEZ Magarpatta city,
Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441 Email sales_at_marketsandmarket
s.com
http//www.linkedin.com/company/marketsandmarkets
http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
11
About MarketsandMarkets
MarketsandMarkets is the global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. MMs flagship competitive intelligence
and market research platform, "RT" connects over
200,000 markets and entire value chains for
deeper understanding of the unmet insights along
with market sizing and forecasts of niche
markets. The new included chapters on Methodology
and Benchmarking presented with high quality
analytical infographics in our reports gives
complete visibility of how the numbers have been
arrived and defend the accuracy of the
numbers. We at MarketsandMarkets are inspired
to help our clients grow by providing apt
business insight with our huge market
intelligence repository.
http//www.marketsandmarkets.com/Market-Reports/eu
ropean-nuclear-medicine-radiopharmaceuticals-marke
t-1107.html
About PowerShow.com